Avantor

From Wikipedia, the free encyclopedia
Avantor, Inc.
TypePublic company
IndustryLife Science, Biopharma, Healthcare, Advanced Technologies, Applied Materials[1][2]
Founded1904; 118 years ago (1904)
HeadquartersRadnor, Pennsylvania, U.S.
Key people
Michael Stubblefield, CEO and President
Brands
OwnerNew Mountain Capital (10%)
Funds advised by Goldman Sachs (13%) [3]
Number of employees
12,400 (2020)
Websiteavantorsciences.com

Avantor, Inc. is a chemicals and materials company headquartered in Radnor, Pennsylvania. The company ranked 484th on the 2020 Fortune 500,[4] based on its 2019 sales.

History[]

In 1904, John Townsend Baker founded the chemical company J.T. Baker. The company was acquired by Procter & Gamble in 1985, and was subsequently sold to Mallinckrodt in 1995.

In 2010, investment firm New Mountain Capital purchased Mallinckrodt Baker Inc., which then changed its name to Avantor.[5] The company expanded globally with the 2011 acquisitions of Indian laboratory reagents supplier RFCL and Polish lab supply firm POCH.[6]

In 2016, Avantor merged with Nusil Technology. In 2017, Avantor acquired chemical blending business Puritan Products Inc. and laboratory supplies company VWR. The combined company operates under the Avantor name, with VWR and vwr.com remaining as a selling channel.[7]

In May 2019, Avantor went public with a $3.8 billion initial public offering, which gave the company a market capitalization of $7.62 billion. This was the second biggest initial public offering of the year.[5] That same year the company expanded further into Asia with the opening of an innovation center in Shanghai, which focuses on monoclonal antibodies and cell and gene therapy.[8] In 2020, Avantor doubled the size of its Bridgewater, New Jersey innovation center, expanding its research and development capabilities and cell and gene therapy reagent manufacturing.[9]

On August 26, 2020, Bloomberg News implicated Avantor and other companies in the U.S. opioid epidemic.[10] Bloomberg claims acetic anhydride produced and sold by these companies in Mexico is used illicitly by drug traffickers to convert crude opium into heroin.[10] Bloomberg alleged the J.T. Baker label of acetic anhydride is highly regarded by drug traffickers.[10] In response, Avantor stated that it followed all applicable regulations in Mexico and only sold to authorized distributors and retailers; however, due to the potential for misuse outside of the regulated supply chain the company out of an abundance of caution discontinued all sales of acetic anhydride in Mexico and destroyed its existing inventory.[11]

In June 2021, Avantor acquired China-based RIM Bio, a manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications. Through the acquisition, Avantor gained access to RIM’s Changzhou, China facility, marking Avantor’s first single-use production plant in the Africa, Middle East, Asia (AMEA) region. The deal is part of a larger expansion of the company’s single-use manufacturing footprint with plans to increase its presence by 30%.[12]

COVID-19[]

During the COVID19 pandemic, Avantor continuously supplied medical-grade and FDA-compliant silicone technology that meets device manufacturers' unique production needs.[13]

In 2020, Avantor began providing services and raw materials to companies manufacturing vaccines and other therapies to fight the COVID-19 pandemic. Avantor added employees and extra shifts in order to increase capacity for producing synthetic lipids that are formed into nanoparticles, which carry mRNA into human cells.[14][15]

Industries[]

Avantor provides products and services to the biopharma, healthcare, education and government, advanced technologies, and applied materials industries.[1][2] The company has more than 6 million different products.[15]

Avantor serves the biopharma industry by enhancing capabilities in the development and manufacture of safe and effective biological medicines such as monoclonal antibodies and cell and gene therapy. The company provides access to products, services, solutions and expertise for all stages of treatment development.[8]

Avantor’s NuSil brand provides silicone solutions for long-term implantable devices, including high-purity silicone adhesives and lubricious silicones. A dispensing system developed by NuSil injects pre-sterilized silicone directly into the body, allowing the material to conform to the patient's anatomy and cure into its final form, creating a custom-fit device.[13]

Recognition[]

In 2021, Avantor was named "Best Bioprocessing Supplier in Single-Use Manufacturing" at the Asia-Pacific Bioprocessing Excellence Awards[16] and "Best Company in Bioprocessing Excellence for Single-use Solutions" and "Best Bioprocessing Supplier for Upstream Processing" at Biologics Manufacturing Korea.[17]

References[]

  1. ^ a b Avantor Inc., Bloomberg, retrieved September 1, 2021
  2. ^ a b Avantor Inc., The Wall Street Journal, retrieved September 1, 2021
  3. ^ SEC Report
  4. ^ Fortune .com
  5. ^ a b Hytha, Michael; Cortez, Michelle Fay (16 May 2019). "Avantor Gets Modest Trade Debut Bump After $2.9 Billion IPO". Bloomberg News. Retrieved 13 September 2021.
  6. ^ Reisch, Marc S. (17 November 2014). "Separating From A Corporate Parent". Chemical & Engineering News.
  7. ^ Harris, Jon. "Center Valley's Avantor involved in $6.4B deal that could create Fortune 500 company". Lehigh Valley Business Cycle. Retrieved 2021-09-11.
  8. ^ a b Avantor opens customer support centre in Shanghai, BioSpectrum Asia, December 12, 2019, retrieved September 18, 2021CS1 maint: date and year (link)
  9. ^ Avantor Expands Life Sciences Innovation Center, Genetic Engineering & Biotechnology News, July 9, 2020, retrieved September 28, 2021CS1 maint: date and year (link)
  10. ^ a b c "Heroin's Hidden Ingredient Is a Chemical Made by U.S. Companies". Bloomberg.com. 2020-08-26. Retrieved 2020-09-07.
  11. ^ Smith, Michael; Cattan, Nacha; Simpson, Cam (15 September 2020). "Avantor Stops Sale of Chemical in Mexico Used to Make Heroin". Bloomberg. Retrieved 8 September 2021.
  12. ^ Stanton, Dan (June 2, 2021), Avantor boosts single-use production with RIM buy, BioProcess International, retrieved September 1, 2021CS1 maint: date and year (link)
  13. ^ a b Hagerty, Hayley (1 April 2021). "How Medical-Grade Silicone Is Advancing Reliable Patient Care". Plastics Today.
  14. ^ Dalton, Matthew; Walker, Joseph (19 December 2020). "Covid-19 Vaccine Makers Tap Contractors to Produce Billions of Doses". The Wall Street Journal. Retrieved 25 September 2021.
  15. ^ a b "How Avantor helps in the vaccine supply chain". CNBC. 21 December 2020. Retrieved 25 September 2021.
  16. ^ Author, "Avantor receives recognition for helping transform biologics production," BioSpectrum, 6 April 2021.
  17. ^ "Avantor recognized for advancing biopharmaceutical manufacturing and enabling efficiencies in upstream processes," BioSpectrum, 25 June 2021.

External links[]

Retrieved from ""